Terbinafin-Mepha 125, Tabletten

7680571740012 CH-57174 Tabletten
Terbinafin-Mepha 125, Tabletten
Terbinafin-Mepha 125, Tabletten
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
14
Selling units
14
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
25/07/2026
Patient information leaflet
Français
25/07/2026
Patient information leaflet
Italien
25/07/2026
Summary of Product Characteristics
Allemand
25/07/2026
Summary of Product Characteristics
Français
25/07/2026
Summary of Product Characteristics
Italien
25/07/2026

Detailed composition

Substance Quantity Type Category
terbinafinum
125.0 MG Substance Wirkstoff (Principe actif)
terbinafini hydrochloridum
- Substance WIZUS
cellulosum microcristallinum
- Substance HNIDK
hypromellosum
- Substance HNIDK
carboxymethylamylum natricum A
- Substance HNIDK
natrium
0.94 MG Substance HBESI
silica colloidalis anhydrica
- Substance HNIDK
magnesii stearas
- Substance HNIDK

Reimbursement information

Public price
CHF 30.40
Specialties list
Yes
Generic
Yes
SL addition date: 01/08/2005

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
57174
Drug name
Terbinafin-Mepha, Tabletten
Galenic form
TAB
ATC Code
D01BA02
Authorization status
Z
Dispensing category
B
First authorization
15/02/2005
Authorization expiration date
31/12/9999
IT Number
08.06.0.
Domain
Human medicine
Field of application
Antimykotikum

Package details

Description (FR)
TERBINAFIN Mepha cpr 125 mg 14 pce
Description (DE)
TERBINAFIN Mepha Tabl 125 mg 14 Stk
Market launch
15/02/2005
Narcotic (BTM)
No

Other package sizes (2)

TERBINAFIN Mepha cpr 250 mg 14 pce
14 TABL
GTIN: 7680571740036
View
TERBINAFIN Mepha cpr 250 mg 28 pce
28 TABL
GTIN: 7680571740050
View
Buy us a coffee Explore the data